Effects of Curculigoside on Memory Impairment and Bone Loss via Anti-Oxidative Character in APP/PS1 Mutated Transgenic MiceLu Zhao(Shanghai Jiao Tong University), Ming Yin(Brigham and Women's Hospital)PLoS ONEJuly 17, 201510.1371/journal.pone.0133289Cited by 32SaveCiteExport RISWatch citationsRelated PapersOcrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial|The Lancet|2011|743Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study|The Lancet|2021|456